Patents by Inventor Xiaoju Wang

Xiaoju Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for preparation of lignin-based latex for binding and coating applications
    Publication number: 20250382425
    Abstract: According to an example aspect of the present invention, here is provided a lignin ether grafted with poly(alkyl acrylate), a latex comprising a lignin ether grafted with poly(alkyl acrylate), and a method of manufacturing a biobased latex comprising the steps of providing an allylated lignin ether derivative and grafting the allylated lignin ether derivative with a poly(alkyl acrylate) by emulsion polymerization, a biobased film formed by the said latex or said method and the use of the latex.
    Type: Application
    Filed: June 21, 2023
    Publication date: December 18, 2025
    Inventors: Luyao Wang, Xiaoju Wang, Patrik Eklund, Rajesh Koppolu, Martti Toivakka, Chunlin Xu
  • Ink formulation, method of producing the same and uses of the ink formulation
    Publication number: 20250320367
    Abstract: The present invention relates to ink formulations based on methacrylated cellulose nanofibrils. In particular, the present invention concerns ink formulations for 3D printing, comprising a hydrogel containing methacrylated cellulose nanofibrils and preferably a cross-linking agent, optionally together with biological material, methods of producing such ink formulations, as well as uses thereof for, e.g., preparing 3D hydrogel scaffolds for cell culture and drug screening.
    Type: Application
    Filed: May 24, 2023
    Publication date: October 16, 2025
    Inventors: Xiaoju Wang, Yury Brusentsev, Wenyang Xu, Chunlin Xu, Lars Wågberg, Oskar Backman, Stefan Willför
  • Using phage epitopes to profile the immune response
    Patent number: 11307203
    Abstract: The present disclosure provides compositions and methods for using one or more polypeptide probes to profile an immune response. The polypeptide probe can be used to detect one or more antibodies from a sample. Furthermore, the present disclosure provides methods and compositions for characterizing a cancer based on the detection of one or more antibodies, such as autoantibodies.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: April 19, 2022
    Assignees: The Regents of the University of Michigan, Exact Sciences Development Company, LLC
    Inventors: Arul M. Chinnaiyan, Xiaoju Wang, Alex Tsodikov, Jeanne Ohrnberger
  • ERG targeted therapy
    Patent number: 10774122
    Abstract: The present disclosure relates to compositions and methods for cancer therapy, including but not limited to, targeted inhibition of cancer markers. In particular, the present disclosure relates to recurrent gene fusions as clinical targets for cancer.
    Type: Grant
    Filed: March 19, 2018
    Date of Patent: September 15, 2020
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Arul Chinnaiyan, Xiaoju Wang
  • ERG TARGETED THERAPY
    Publication number: 20180273595
    Abstract: The present disclosure relates to compositions and methods for cancer therapy, including but not limited to, targeted inhibition of cancer markers. In particular, the present disclosure relates to recurrent gene fusions as clinical targets for cancer.
    Type: Application
    Filed: March 19, 2018
    Publication date: September 27, 2018
    Inventors: Arul Chinnaiyan, Xiaoju Wang
  • PHAGE MICROARRAY PROFILING OF THE HUMORAL RESPONSE TO DISEASE
    Publication number: 20180265861
    Abstract: The present invention relates to compositions and methods for cancer diagnostics, including but not limited to, cancer markers. In particular, the present invention provides methods and compositions for phage microarray profiling of cancer (e.g., prostate, lung, or breast cancer). The present invention further provides novel markers useful for the diagnosis, characterization, and treatment of cancers.
    Type: Application
    Filed: June 4, 2018
    Publication date: September 20, 2018
    Inventors: Arul M. Chinnaiyan, Xiaoju Wang
  • USING PHAGE EPITOPES TO PROFILE THE IMMUNE RESPONSE
    Publication number: 20180224455
    Abstract: The present disclosure provides compositions and methods for using one or more polypeptide probes to profile an immune response. The polypeptide probe can be used to detect one or more antibodies from a sample. Furthermore, the present disclosure provides methods and compositions for characterizing a cancer based on the detection of one or more antibodies, such as autoantibodies.
    Type: Application
    Filed: March 23, 2018
    Publication date: August 9, 2018
    Inventors: Arul M. Chinnaiyan, Xiaoju Wang, Alex Tsodikov, Jeanne Ohrnberger
  • Phage microarray profiling of the humoral response to disease
    Patent number: 10006023
    Abstract: The present invention relates to compositions and methods for cancer diagnostics, including but not limited to, cancer markers. In particular, the present invention provides methods and compositions for phage microarray profiling of cancer (e.g., prostate, lung, or breast cancer). The present invention further provides novel markers useful for the diagnosis, characterization, and treatment of cancers.
    Type: Grant
    Filed: January 12, 2016
    Date of Patent: June 26, 2018
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Arul M. Chinnaiyan, Xiaoju Wang
  • Using phage epitopes to profile the immune response
    Patent number: 9658231
    Abstract: The present disclosure provides compositions and methods for using one or more polypeptide probes to profile an immune response. The polypeptide probe can be used to detect one or more antibodies from a sample. Furthermore, the present disclosure provides methods and compositions for characterizing a cancer based on the detection of one or more antibodies, such as autoantibodies.
    Type: Grant
    Filed: August 10, 2015
    Date of Patent: May 23, 2017
    Assignees: The Regents of the University of Michigan, Armune Biosciences, Inc.
    Inventors: Arul M. Chinnaiyan, Xiaoju Wang, Alex Tsodikov, Jeanne Ohrnberger
  • PHAGE MICROARRAY PROFILING OF THE HUMORAL RESPONSE TO DISEASE
    Publication number: 20160264959
    Abstract: The present invention relates to compositions and methods for cancer diagnostics, including but not limited to, cancer markers. In particular, the present invention provides methods and compositions for phage microarray profiling of cancer (e.g., prostate, lung, or breast cancer). The present invention further provides novel markers useful for the diagnosis, characterization, and treatment of cancers.
    Type: Application
    Filed: January 12, 2016
    Publication date: September 15, 2016
    Inventors: Arul M. Chinnaiyan, Xiaoju Wang
  • Phage microarray profiling of the humoral response to disease
    Patent number: 9267133
    Abstract: The present invention relates to compositions and methods for cancer diagnostics, including but not limited to, cancer markers. In particular, the present invention provides methods and compositions for phage microarray profiling of cancer (e.g., prostate, lung, or breast cancer). The present invention further provides novel markers useful for the diagnosis, characterization, and treatment of cancers.
    Type: Grant
    Filed: October 28, 2010
    Date of Patent: February 23, 2016
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Arul Chinnaiyan, Xiaoju Wang
  • USING PHAGE EPITOPES TO PROFILE THE IMMUNE RESPONSE
    Publication number: 20160041174
    Abstract: The present disclosure provides compositions and methods for using one or more polypeptide probes to profile an immune response. The polypeptide probe can be used to detect one or more antibodies from a sample. Furthermore, the present disclosure provides methods and compositions for characterizing a cancer based on the detection of one or more antibodies, such as autoantibodies.
    Type: Application
    Filed: August 10, 2015
    Publication date: February 11, 2016
    Inventors: Arul M. Chinnaiyan, Xiaoju Wang, Alex Tsodikov, Jeanne Ohrnberger
  • Gene fusion targeted therapy
    Patent number: 8759301
    Abstract: The present invention relates to compositions and methods for cancer therapy, including but not limited to, targeted inhibition of cancer markers. In particular, the present invention relates to recurrent gene fusions as clinical targets for prostate cancer.
    Type: Grant
    Filed: February 10, 2011
    Date of Patent: June 24, 2014
    Assignee: The Regents of The University of Michigan
    Inventors: Arul M. Chinnaiyan, Xiaoju Wang, Ram Shankar Mani
  • Methods and compositions for diagnosing prostate cancer
    Patent number: 8617547
    Abstract: The present invention relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to ubiquilin 1 markers for cancer.
    Type: Grant
    Filed: September 10, 2009
    Date of Patent: December 31, 2013
    Assignee: The Regents of The University of Michigan
    Inventors: Arul Chinnaiyan, David Beer, Guoan Chen, Xiaoju Wang
  • USING PHAGE EPITOPES TO PROFILE THE IMMUNE RESPONSE
    Publication number: 20110237461
    Abstract: The present disclosure provides compositions and methods for using one or more polypeptide probes to profile an immune response. The polypeptide probe can be used to detect one or more antibodies from a sample. Furthermore, the present disclosure provides methods and compositions for characterizing a cancer based on the detection of one or more antibodies, such as autoantibodies.
    Type: Application
    Filed: March 17, 2011
    Publication date: September 29, 2011
    Applicants: THE REGENTS OF THE UNIVERSITY OF MICHIGAN, ARMUNE BIOSCIENCES, INC.
    Inventors: Arul M. Chinnaiyan, Xiaoju Wang, Alex Tsodikov, Jeanne Ohrnberger
  • GENE FUSION TARGETED THERAPY
    Publication number: 20110207675
    Abstract: The present invention relates to compositions and methods for cancer therapy, including but not limited to, targeted inhibition of cancer markers. In particular, the present invention relates to recurrent gene fusions as clinical targets for prostate cancer.
    Type: Application
    Filed: February 10, 2011
    Publication date: August 25, 2011
    Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Arul M. Chinnaiyan, Xiaoju Wang, Ram Shankar Mani
  • PHAGE MICROARRAY PROFILING OF THE HUMORAL RESPONSE TO DISEASE
    Publication number: 20110070652
    Abstract: The present invention relates to compositions and methods for cancer diagnostics, including but not limited to, cancer markers. In particular, the present invention provides methods and compositions for phage microarray profiling of cancer (e.g., prostate, lung, or breast cancer). The present invention further provides novel markers useful for the diagnosis, characterization, and treatment of cancers.
    Type: Application
    Filed: October 28, 2010
    Publication date: March 24, 2011
    Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: ARUL CHINNAIYAN, XIAOJU WANG
  • Phage microarray profiling of the humoral response to disease
    Patent number: 7858323
    Abstract: The present invention relates to compositions and methods for cancer diagnostics, including but not limited to, cancer markers. In particular, the present invention provides methods and compositions for phage microarray profiling of cancer (e.g., prostate, lung, or breast cancer). The present invention further provides novel markers useful for the diagnosis, characterization, and treatment of cancers.
    Type: Grant
    Filed: June 6, 2005
    Date of Patent: December 28, 2010
    Assignee: The Regents of the University of Michigan
    Inventors: Arul Chinnaiyan, Xiaoju Wang
  • METHODS AND COMPOSITIONS FOR DIAGNOSING LUNG CANCER
    Publication number: 20100009382
    Abstract: The present invention relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to ubiquilin 1 markers for cancer.
    Type: Application
    Filed: September 10, 2009
    Publication date: January 14, 2010
    Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Arul Chinnaiyan, David Beer, Guoan Chen, Xiaoju Wang
  • Methods and compositions for diagnosing lung cancer
    Patent number: 7597890
    Abstract: The present invention relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to ubiquilin 1 markers for cancer.
    Type: Grant
    Filed: March 8, 2007
    Date of Patent: October 6, 2009
    Assignee: The Regents of the University of Michigan
    Inventors: Arul Chinnaiyan, David Beer, Guoan Chen, Xiaoju Wang